Illumina Inc ILMN

NAS: ILMN | ISIN: US4523271090 23/05/2025

80,37 USD (-0,21%)

(-0,21%) 23/05/2025

Grafiek Illumina Inc

Grafiek Illumina Inc

1 dag1d -0,21%
1 week1w -3,11%
1 maand1m 3,90%
3 maanden3m -16,07%
6 maanden6m -44,12%
1 jaar1j -23,48%
5 jaar5j -77,32%

Illumina Inc in het nieuws

Toon enkel gratis nieuws

14 mei 2025 · Illumina To Webcast Upcoming Investor Conference · Persbericht

13 mei 2025 · Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications · Persbericht

8 mei 2025 · Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 · Persbericht

1 mei 2025 · Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development · Persbericht

15 april 2025 · Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation · Persbericht

10 april 2025 · Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 · Persbericht

25 maart 2025 · Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors · Persbericht

19 maart 2025 · Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery · Persbericht

10 maart 2025 · Illumina addresses recent developments in China · Persbericht

6 maart 2025 · Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year · Persbericht

Profiel Illumina Inc

Gezondheidstechnologie

Productie van analytische laboratoriuminstrumenten

Website: www.illumina.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: Francis deSouza

Werknemers: 10.007

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe